Medical Devices Startups
5,183 companies tagged Medical Devices, with their investors and founders.
Enedra analyzes tumor evolution patterns by decoding convergent genomic signatures from cancer genomic data. The company uses its CASPAROV platform to identify conserved genetic patterns across tumor populations and cancer models.
3 investors
Enhatch provides a HIPAA-compliant, web-based platform for personalized surgery, letting surgical teams, engineers, and device reps generate anatomic models, create patient-specific case plans, and collaborate on approvals remotely. The platform integrates with 3D Systems for additive manufacturing so users can export design files to 3D-printed surgical solutions.
3 investors
EnsiliTech develops ensilication technology, a silica-based method to stabilise vaccines and biopharmaceuticals so they can be stored and transported without refrigeration. The company serves the pharmaceutical and biotech industry and originated from research at the University of Bath.
3 investors
Enspectra Health develops VIO, a handheld skin imaging system that combines multiphoton laser scanning with reflectance confocal microscopy to produce high-resolution digital images of live cells noninvasively, without a biopsy incision. The technology provides AI-powered cellular insights for dermatology and skin health assessment.
3 investors
Entac Medical develops wearable devices that apply predictive analytics and AI to biological acoustic signals to predict patient adverse events, aiming to improve patient outcomes and reduce hospital readmissions and cost of care. It serves the healthcare sector as a digital health company.
3 investors
ENYO Pharma is a clinical-stage biopharmaceutical company developing therapeutics for patients with impaired kidney function. Its lead compound, VONAFEXOR, is a small molecule with fibrolytic and anti-inflammatory properties in Phase 2 development for rare kidney disease Alport Syndrome and Chronic Kidney Diseases.</parameter> <parameter name="founders">[]
3 investors
Epiodyne develops small-molecule opioids designed to optimize therapeutic outcomes, with initial focus on safer pain relief and improved opioid use disorder treatment with reduced addiction and respiratory depression risk. The company uses a platform approach to tune drug candidates across a spectrum from inhibitors to full agonists.
3 investors
Epirium Bio develops novel oral therapeutics targeting mitochondrial dysfunction and muscle diseases, particularly muscular dystrophy. The company's lead compound, EPM-01, is in Phase 1 clinical development for Becker muscular dystrophy.
3 investors
Epitel is a digital health company that builds REMI, a wearable, wireless cloud-based EEG monitoring system with AI-based seizure event detection for use in healthcare and ambulatory settings. Its FDA-cleared platform serves physicians and patients (adult and pediatric) needing remote electrographic seizure monitoring in the U.S.
3 investors
EpiWatch is an FDA-cleared seizure detection app for Apple Watch that monitors for tonic-clonic seizures and sends real-time alerts to users and their caregivers. The app is designed for people with epilepsy in the United States to help reduce the risk of sudden unexpected death in epilepsy (SUDEP) and enable faster intervention.
3 investors
Essenvia offers a regulatory information management platform for medical device regulatory affairs teams, automating submissions (including FDA eSTAR), centralizing registrations, and providing AI-driven regulatory intelligence and lifecycle tracking. It integrates with existing systems such as PLM, eQMS, and ERP and supports compliance frameworks including SOC 2, GxP, 21 CFR Part 11, and GDPR.
3 investors
Fabric Genomics provides an AI-based platform for next-generation sequencing (NGS) analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The platform serves hospitals, clinical laboratories, and academic medical centers.
3 investors
FastDoctor operates a Japanese telemedicine and house-call service that connects patients with physicians through video consultations and in-home emergency visits, available nights, weekends, and year-round. It works with a network of partner medical institutions across Japan, accepts health insurance, and can arrange prescriptions.
3 investors
FemSelect develops EnPlace, an FDA-cleared, minimally invasive same-day treatment for Pelvic Organ Prolapse in women. The device addresses dropping of the uterus and cervix by supporting the pelvic floor, offering an alternative to pessaries, physical therapy, and Kegels.
3 investors
FineHeart develops FlowMakerยฎ, a therapeutic device for treating advanced heart failure. The company is a clinical-stage medtech organization based in France.
3 investors
1STBIO (ํผ์คํธ๋ฐ์ด์ค) is a biotechnology company developing drug programs, including the HPK1 inhibitor immuno-oncology candidate FB849 and the NLY02 program. It focuses on advancing therapeutic pipelines to bring treatments to patients.
3 investors
First Light Diagnostics develops the MultiPath benchtop analyzer, an instrument for rapid diagnostic testing. The company operates in the in-vitro diagnostics space.
3 investors
Flex Pharma provides accessible generic vasodilator medications, including PDE5 inhibitors, to U.S. patients at lower costs than brand-name alternatives. The company focuses on vessel health and blood flow optimization for applications ranging from athletic performance to sexual wellness.
3 investors
Float operates a technology platform that enables nurses to administer specialty medications to patients at home, serving patients requiring specialty infusions and healthcare providers seeking to shift treatment delivery from hospitals and clinics. The company operates in home-based healthcare and digital health technology.
3 investors
Forge Biologics is a US-based gene therapy CDMO (contract development and manufacturing organization) offering AAV manufacturing services, technologies, and infrastructure. It supports gene therapy developers across early development, clinical trials, and commercial production, and is a subsidiary of the Ajinomoto Group.
3 investors
Fractyl develops therapies for obesity and type 2 diabetes, focusing on non-drug-based approaches rooted in understanding metabolic disease mechanisms. The company serves patients and the physician community seeking alternatives to lifelong pharmaceutical treatments.
3 investors
Freespira is a medication-free treatment device that uses breathing regulation training to address panic attacks and PTSD symptoms. The platform combines a breathing sensor, tablet app with real-time feedback, and support from a care specialist to teach users breathing pattern control over a 28-day program.
3 investors
GAIA BioMedicine (ๆ ชๅผไผ็คพใฌใคใขใใคใชใกใใฃใทใณ) develops GAIA-NK, a cell therapy using engineered cells with high cytotoxic activity against solid tumors, based on research from Kyushu University. The company researches, develops, and manufactures regenerative medicine products aimed at curative cancer treatment.
3 investors
Galen Data, Ltd (acquired by Matrix One in December 2024) offers Matrix Connect, a cloud connectivity platform for medical devices that provides a native SDK, web API, configurable dashboards, and compliance frameworks aligned with IEC 62304, HIPAA, GDPR, FDA, and EU MDR. It serves medical device manufacturers and innovators looking to connect devices to the cloud without building custom infrastructure.
3 investors